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ABSTRACT
Objective: The present study aimed to estimate and
compare the economic impact of Schmallenberg virus
(SBV) in different sheep production holdings using
partial budget and gross margin analyses in
combination with production models.
Participants: The sheep production types considered
were lowland spring lambing, upland spring lambing
and early lambing flocks in the UK, and grass lamb
flocks of the Centre and West of France, extensive
lambing flocks and dairy sheep flocks in France.
Methodology: Two disease scenarios with distinct
input parameters associated with reproductive
problems were considered: low and high impact.
Sensitivity analyses were performed for the most
uncertain input parameters, and the models were run
with all of the lowest and highest values to estimate
the range of disease impact.
Results: The estimated net SBV disease cost per year
and ewe for the UK was £19.65–£20.85 for the high
impact scenario and £6.40–£6.58 for the low impact
scenario. No major differences were observed between
the different production types. For France, the net SBV
disease cost per year and ewe for the meat sheep
holdings was £15.59–£17.20 for the high impact
scenario and £4.75–£5.26 for the low impact scenario.
For the dairy sheep, the costs per year and ewe were
£29.81 for the high impact scenario and £10.34 for the
low impact scenario.
Conclusions: The models represent a useful decision
support tool for farmers and veterinarians who are
facing decisions regarding disease control measures.
They allow estimating disease impact on a farm
accounting for differing production practices, which
creates the necessary basis for cost effectiveness
analysis of intervention strategies, such as vaccination.
INTRODUCTION
Schmallenberg virus (SBV) is a novel ortho-
bunyavirus that was first detected in
November 2011 in Germany in cattle with
fever and reduced milk yield (Hoffmann and
others 2012). SBV affects ruminants and
appears to be exclusively transmitted by insect
vectors of the Culicoides species group and ver-
tically in utero (European Food Safety
Authority 2012, Garigliany and others 2012b,
Beer and others 2013). The very rapid spread
and virus circulation described in spring 2013
(European Food Safety Authority 2013)
sparked renewed discussions about SBV trans-
mission patterns. Following expansive spread
in various European countries, the virus was
officially declared endemic in Belgium,
France, Germany, Italy, Luxembourg, The
Netherlands, Spain, Switzerland and the UK
at the end of May 2012. The virus was
detected by reverse transcription PCR in
cattle, sheep, goats, alpacas, buffalos, bison,
deer and moose, while fallow deer, roe deer
and red deer were found to be seropositive
(European Food Safety Authority 2013). It is
unlikely that SBV causes disease in humans,
but the possibility could not be completely
excluded (European Centre for Disease
Prevention and Control 2011, Reusken and
others 2012).
Physiopathology and immunity of SBV
remains imprecise. SBV detection in blood
was reported to occur up to 15 days after
natural infection (Claine and others 2013).
Animals infected with SBV could develop
immunoprotection which may prevent
repeated infection for at least 2 months
(Inaba and Matumoto 1990, Elbers and
others 2012, Garigliany and others 2012a,
Wernike and others 2013).
In ruminants, clinical signs are mainly
associated with reproductive disorders.
Depending on the time of infection, abor-
tion, stillborn animals, premature deliveries
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and various intrauterine congenital malformations may
occur (Steukers and others 2012, Conraths and others
2013). SBV has been detected in malformed fetuses,
stillborn lambs or lambs born at term but with signs of
neurological disorders, such as blindness, deafness,
recumbency, an inability to suck and convulsions
(Lievaart-Peterson and others 2012, Steukers and
others 2012). Clinical signs are not observed in adult
or growing sheep, although there were some reports of
diarrhoea of unknown cause in ewes (Beer and others
2013) and anecdotal evidence of milk drop in milking
sheep in The Netherlands (Anonymous 2011). Such
acute infections cause production losses in terms of
animals and milk lost and require additional expendi-
tures for palliative treatment of affected animals.
Additionally, trade or movement regulations may be a
further economic cost for farmers, because of immobil-
isation of infected animals and extra costs due to
specific export requirements to SBV free countries
(EFSA 2014).
For a farmer to take an informed decision on a
potential investment for an intervention on the farm to
control a disease like SBV, it is critical to know whether
the costs of an intervention are less that the financial
losses associated with SBV. To be able to make a judg-
ment on a potential investment for disease control, it is
a necessary first step to estimate the impact of disease
as a baseline. Interventions may include vaccination,
which induces specific neutralising antibodies against
the virus in the dam, preventing the virus from reach-
ing the fetus; reduction of exposure to the vector
through disruption of vector breeding sites, pesticide
use, housing and protection of ruminants by repel-
lents, and management of the timing of service or
insemination (Baylis and others 2010, Anonymous
2012, British Cattle Veterinary Association 2012). The
latter may prove difficult in many European countries
where production and management systems are tar-
geted towards the seasonality of grass growth and
market demand.
Because the production type and associated manage-
ment decisions and husbandry practices impact on the
magnitude of losses and expenditures associated with
disease (Häsler B. and others, unpublished observa-
tions), it is important to take into account the produc-
tion structure. This allows not only determination of the
disease impact with more accuracy, but also allows for
investigation of which production factors cause the
highest costs related to disease.
The purpose of this study was to estimate the eco-
nomic impact of SBV at the farm level in the UK and
France for the most common sheep production types.
The objectives were: (1) to develop sheep production
models as a basis for the financial analysis of SBV in
sheep farms; (2) to calculate the partial budget for SBV
in the UK and France; and (3) to investigate potential
differences in model variables and disease estimates
between the two countries.
METHODOLOGY
Overview
The SBV disease cost was calculated in three steps. First,
the most typical and frequent production types of sheep
in the UK and France were identified and modelled in
Microsoft Excel. These production models simulated the
farm population dynamics for a 1 year cycle using a
static model, meaning that animal inputs and outputs
(e.g. number of lambs finished or number of ewes
bought for replacement) were recorded at the end of
the cycle. Secondly, gross margin models were developed
based on the production models. This was done by
adding price level data and other economic parameters
(such as veterinary costs) to the outcome of the produc-
tion models in order to calculate the annual gross
benefit of each system. To validate these models, the
annual gross margins obtained for each system were
compared with published gross margins. Thirdly, SBV
disease effects were included in the production and
gross margin models by adjusting respective parameters
(e.g. proportion of lambs stillborn) or adding new ones
(e.g. disposal costs for lambs that died because of SBV).
These models were then run with and without disease,
and the differences obtained were used to estimate the
extra costs and extra benefits of SBV disease in a partial
budget analysis. Two SBV disease scenarios—namely
high and low impact scenarios—were investigated.
Values for the disease parameters for each scenario were
obtained from the existing literature and by expert
opinion consultation. Sensitivity analyses were conducted
to assess the variability of the disease impact for different
combinations of the two most important disease param-
eter values. The methodology used is based on a
concept article available on request (Häsler B. and
others, unpublished observations).
Sheep production models
Available benchmarking data and expert opinion were
used to identify the most common and representative
sheep farm types in the UK and France. In total, three
production types were identified for the UK and three
for France (Table 1).
For the UK, the farm types were differentiated based
on geographic location (upland v lowland) and lambing
season (spring v early lambing). Dairy sheep holdings
were not considered because their numbers are rela-
tively low in the UK. In France, two meat and one dairy
production types were modelled. They differed by area
and intensity level, as previously described by the French
livestock institute (Institut Elevage Ovin viande 2013).
The model ‘grass lamb flocks of the Centre and West of
France’ (GLCW) represents the moderate to high inten-
sive sheep production that takes place in Massif Central
and the West of France. The model ‘extensive lambing
flocks’ (EL) represents extensive uplands or low produ-
cing areas. The dairy sheep production type modelled is
the Massif Central Lacaune breed based system.
It accounts for 75 per cent of the sheep milk produced
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in France, and is linked to the production of Roquefort
cheese. Corse and South-West dairy production types
were not included as their farming systems differ highly
from the Roquefort one and only represent a small pro-
portion of the dairy sheep production in France.
For the development of the production models, which
simulated a 1 year cycle, benchmarking data from differ-
ent independent sources based on farm surveys and
actual expenditures made by farmers were used for both
the UK (Scottish Agricultural College 2010, Agro
Business Consultants 2012, EBLEX, 2012, Nix 2013) and
France (Institut Elevage Ovin lait 2012, Institut Elevage
Ovin viande 2013). Some of the available benchmarking
data were complemented by other sources, such as the
authors’ expertise and published statistics on market
prices. For example, expenditures in France were avail-
able for the whole farm, but not disaggregated by the
different classes of animals, and thus needed to be
broken down using the authors’ professional judgment.
The full production models can be found in the online
Table 1 in supplement 2.
Estimation of annual gross margins
The production models were used to estimate the annual
gross margin for the different production types (Eq. 1):
Gross margin¼ Revenue
Replacement costs and breeding depreciation
Feed costsVeterinary costs other variable costs
ð1Þ
The detailed calculations of revenues and costs were
done as described elsewhere (Häsler B. and others,
unpublished observations) and are given in Table 2. All
of the data used for the development of the production
TABLE 1: Description of the sheep production types in the UK and France considered in this study
Country Farm types Description
UK Lowland spring lambing farms Sheep and lambs are raised in good grasslands. The ewes are mated in
September/October. Lambs are born in April and sold in August/September.
Some lambs are fattened and sold in April the following year (store lambs*).
Use of crossbreeds. Main breeds are Suffolk, Texel and Dorset. Production
of large and muscular lambs for meat. Ewes tend to produce higher number
of lambs.
UK Upland spring lambing farms Sheep and lambs are raised in relatively poor grasslands and therefore
require extra quantity of concentrates in their feed. Breeding cycle similar to
lowlands, but with poorer performance. Animals are more resistant to
adverse weather conditions. These farms tend to have more pure bred
animals and normally replace their ewes with their own lambs.
UK Lowland early lambing farms Lambs are born between December and February, when grass is less rich.
Therefore, extra concentrates are normally required in the feed. Good
housing is required to account for winter conditions. Lambs are sold in the
spring when prices are high.
FR Grass lamb flocks of the Centre and
West France (GLCW)
Lambs are mainly finished in barns with high level of concentrates. Several
reproduction managements possible: (i) autumn lambing exclusively, (ii)
autumns lambing plus spring lambing for first lambing ewe or (iii) three
lambings within 2 years. Moderate to high level of productivity. Production of
large and muscular lambs for meat. Ewes tend to produce higher number of
lambs. High or moderate level of intensification with several breeds possible.
Lambs sold are fattened (very few store* lambs).
FR Extensive lambing flocks Sheep and lambs are raised in poor grazing lands and therefore have lower
productivity and lower selling weight. Breeding cycle is similar to GLCW, but
with poorer performance. Animals are more resistant to adverse weather
conditions. These farms tend to have more pure breed animals. The
proportion of lambs sold fattened is increased compared with GLCW.
FR Dairy sheep Central France dairy production (Roquefort). Represents 75% of French
dairy sheep production. Lacaune breed. Only one period of lambing per
year. Reproduction of adult occurs in June and July (one month later for first
lambing ewe). Lambing occurs in November and December for adults, and
January and February for first lambing ewes. Lambs are fed with their
mother’s milk and are weaned at 12–13 kg body weight. They are then sold
and fattened in specialised fattening units, to then be slaughtered at
15–19 kg body weight. Milking occurs just after lambing and for 5–8 month.
*Store lambs are lambs that are sold for finishing. Normally smaller lambs are sold in this way so that they have more time to grow and put on
weight
FR, France
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TABLE 2: Revenues and costs calculated in the gross margin analyses for the different sheep production types in the UK and France
Revenues and costs Equations
Revenues
UK-FR: Total finished lambs sales Total young lambs sold×lamb carcase weight (kg) at selling×price per kg carcase weight
UK-FR: Total store lambs sales Total store lambs sold×price of a store lamb
UK-FR: Total cull ewes sales Total ewes culled×cull price per ewe
UK: Total wool sales Total wool sold (kg)×price per kg of wool
FR (dairy): Total female lambs sold for breeding Total lambs sold for breeding×price per lamb for replacement
FR (dairy): Total milk sales Total ewes that milked×milk per ewe milked (litre)×duration of milking (days)×price of milk per litre
Replacement costs
UK-FR: Costs of buying or raising new replacement ewes Total ewes bought×net value of a replacement ewe or net value of raising an ewe
UK-FR: Depreciation of the ram ((Purchase value of a ram−cull value of a ram)/life of a ram in years)×number of ewes/ewe to ram ratio
Feeding costs
UK-FR: Costs of feed concentrate for ewes that lamb Total ewes that lamb×concentrate (kg) per ewe×price per kg concentrate
UK: Costs of feed concentrate for ewes that have aborted Concentrate (kg) per ewe×number of ewes that have aborted×price per kg concentrate
UK-FR: Costs of feed concentrate for finished lambs Total finished lambs sold×concentrate (kg) per lamb sold at weaning×price per kg concentrate
UK-FR: Costs of feed concentrate for store lambs Total store lambs sold×concentrate (kg) per store lamb×price per kg concentrate
UK-FR: Costs of forage for ewes that lamb (Number of ewes×number of ewes per hectare of land)×forage cost per hectare
Veterinary and medicine costs
UK-FR: Costs of ewe vaccines (Cost of chlamydia vaccine+cost of toxoplasma vaccine)×total number of ewes bought+cost of
clostridium and pasteurella vaccine×total number of ewes that lamb
UK-FR: Costs of worming ewes Cost of deworming ewes×total number of ewes that lamb
UK-FR: Costs of lamb vaccines Total number of lambs sold×cost of lamb vaccines (Note: In upland spring farms the number of lambs
kept for replacement is also accounted for)
UK-FR: Costs of lamb worming Total number of lambs sold×cost of deworming (Note: In upland spring farms the number of lambs kept
for replacement is also accounted for)
UK: Costs of disposing dead ewes Disposal costs per ewe×total ewes that die
UK: Costs of disposing dead fetuses, lambs born dead
and lambs that die
Disposal costs per lamb×(total lambs born dead+total lambs that die post partum+total lambs aborted)
UK-FR: Costs of treating ewes with late abortion Total number of ewes with late abortions×proportion of ewes with late abortion that get treated×cost of
treatment per abortion
Other variable costs
UK-FR: Costs of scanning Number of ewes×scanning cost per ewe
UK-FR: Costs of tags Number of ewes×tagging cost per ewe
UK-FR: Costs of bedding Bedding cost per ewe×(total number of ewes that lamb−total number of ewes that give birth to a lamb
stillborn×(1−probability of a ewe with reproductive problems to get culled))×220/365+bedding cost per
ewe×(total number of ewes empty+total number of ewes with late abortions)×(1−probability of an ewe
with reproductive problems to get culled)
UK : Costs of shearing Shearing cost per ewe×(total ewes that lamb+(number of ewes empty+number of ewes with
abortions)×(1−probability of an ewe with reproductive problems to get culled)
UK-FR: Costs of marketing Marketing levy transport cost per ewe×total number of ewes that lamb
UK-FR: Costs of minerals and licks Mineral and lick cost per ewe×total number of ewes that lamb
Input values are specific to each production type. Number and quantities of animals/products indicated in the equations are obtained from the production models (see Table 2 in online
supplement 2)
FR, France
4
Alarcon
P,etal.
VetRec
Open
2014;0:e000036.doi:10.1136/vetreco-2014-000036
O
p
e
n
A
c
c
e
s
s
group.bmj.com
 o
n
 M
arch 23, 2017 - Published by 
http://vetrecordopen.bmj.com/
D
ow
nloaded from
 
models and gross margin analyses are listed in the online
supplement 1.
Assessment of SBV disease impact using partial
budget models
The scientific literature was screened to identify the bio-
logical effects of SBV in sheep. Furthermore, common
management practices were discussed with experts (see
section ‘Software, input values, sensitivity analysis and
validation’ below) and assumptions made regarding
farmers’ reactions to disease (Box 1). The generic pro-
duction and gross margin models were used as the basis
for a partial budget analysis. Biological disease effects
were integrated into these models by, for example,
increasing or decreasing forage use, veterinary costs or
lambs born following a partial budget structure (Eq. 2):
Net valuei ¼ ðCosts savedi þNew revenueiÞ
 ðNew costsi þ Revenue forgoneiÞ ð2Þ
Net value (or net SBV disease cost) represents the
financial impact of disease for a 1 year cycle and i is a
defined disease scenario. This net value does not con-
sider non-monetary impacts, such as the opportunity cost
of labour spent in treating or caring for diseased animals.
To calculate the values of the PBAs (Partial Budget
Analysis), disease parameters were first introduced into
the production models. The differences obtained
between gross margin parameters of disease and no
disease situations were calculated. For example, the pro-
portion of abortions changed the number of lambs
born, which then resulted in lower revenues from lambs
sold. For new costs items, such as ‘treatment of ewes
with abortions’, new parameters where created in the
models as follows:
Cost of caesarean
¼ Total number of ewes with dystocia that
require caesarean CostCes
ð3Þ
Cost of SBV testing in aborted foetuses
¼ Number of fetuses that will be tested for SBV
 CostSBVtest ð4Þ
Whereas CostCes is the costs of a caesarean and
CostSBVtest is the price of SBV diagnostic of one sample
(see online supplement 1).
Data on the within herd SBV incidence, incidence of
various disease effects (e.g. rate of abortion, drop in
milk yield) and the magnitude of those effects (e.g. pro-
portion of milk loss) are sparse. Consequently, only two
scenarios were considered:
▸ Scenario 1: A high impact in a herd that is highly sus-
ceptible to disease, which may, for example, be a
management system where the susceptible gestation
period falls into a season of high vector activity.
▸ Scenario 2: A low impact in a herd that is less suscep-
tible to disease, which may, for example, be a man-
agement system in an area with low vector density.
Box 1: Assumptions made on general management prac-
tices and reactions to Schmallenberg virus (SBV) related
disorders in sheep holdings in the UK and France (FR) to
estimate the impact of SBV
General management practices (without SBV)
UK-FR (meat): The farmers buy all the replacement stock.
FR (dairy): The replacement stock is raised on the farm, extra
female lambs sold for replacement.
Farmers’ reaction to clinical disease
UK-FR: A very small proportion (1%) of ewes will receive treat-
ment (anti-inflammatory) to suppress fever.
Reproductive disorders and related management practices
FR: Wool price and price for shearing (not done by farmer) are
considered to be the same and therefore not included.
UK-FR: A proportion of ewes will have late abortions or will give
birth to stillborn or malformed lambs due to SBV infection. Of all
the malformed lambs born, only 1% will survive and the costs
related to these lambs are considered negligible.
UK-FR: A proportion of ewes with SBV reproductive problems will
be removed from the flock. These will be culled and the meat will
be sold (the cull value for the ewe is applied).
UK-FR: A proportion of ewes will die due to SBV reproductive
problems (the market value for the ewe is applied).
UK-FR (meat): The proportion of finished lambs and store lambs
sold remains the same with SBV infection (while absolute
numbers may differ due to disease).
UK-FR: In some cases, the malformations will lead to dystocia
and the veterinarian will be called out. In a few cases of dystocia
farmers will agree to conduct a caesarean.
UK-FR: When the ewe gives birth to a stillborn or a malformed
lamb and there is no dystocia, there will not be any veterinary
treatment.
UK-FR: In the case of an abortion, there may be treatment by the
farmer. When ≥3% of ewes present abortions, the veterinarian
will be called to investigate.
UK: The costs of culling a lamb is negligible (done by the
farmer).
FR: The costs of disposing a dead animal is null, since this is
paid through a tax at slaughtering of normal animals.
UK-FR: Malformed and/or stillborn lambs are unlikely to be sub-
mitted for testing because farmers may already suspect SBV,
whereas an aborted lamb may be submitted on rare occasions.
FR: Concentrates are mainly fed 5 weeks before and several
weeks after the lambing. Feed concentrate will be saved in case of
late abortion.
UK: Concentrates saved considered to be negligible.
FR (dairy): Milk production decreases because of ewes dead or
culled and not replaced in the current year and because of a drop
in milk production during clinical episodes.
Drop in milk production induces reduced concentrate consump-
tion for ewes with clinical cases.
Note: Unless specified, the assumptions apply both to meat and
dairy sheep. These were agreed during the expert workshop
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TABLE 3: Parameters and values used for a high impact and low impact Schmallenberg virus disease scenario
Parameter
Scenario 1—
high impact
Scenario 2—
low impact Reference Reasoning
Number of ewes with late abortion due to
SBV out of a flock with 100 ewes
1–3.5
most likely=3
1–2
most
likely=1.5
(Saegerman and others 2013)
and expert opinion
Difference in abortion rate between positive and negative
flocks from Saegerman and others 2013 was 3%. This
value reflects the mean in the high impact scenario and
acts as reference point for the expert estimates.
Number of ewes that will get treated
(antibiotics) out of 100 ewes with late
abortions
1 1 Expert opinion The vast majority of farmers do not apply antibiotic
treatment after abortion in ewes.
Number of aborted fetuses that will be
submitted for SBV testing out of 100
aborted fetuses
0 0 Expert opinion Because there is no requirement to submit aborted
fetuses for testing when numbers are low, farmers are
highly unlikely to submit aborted fetuses for testing.
Number of lambs stillborn or malformed
and those that die within 1 week after
lambing due to SBV out of 100 lambs born
2–12
most likely=7
1–3
most likely=2
(Saegerman and others 2013),
(Van den Brom and others
2012), (GDS France, 2012) and
expert opinion
Saegerman and others 2013: 23.3% in SBV positive
flocks and 11.5% in SBV negative flocks showed
stillborn, dead at birth and malformed lambs. Difference
11.8%.
GDS France 2012: 13% of lambs aborted, stillborn, dead
at birth and 2% malformed lambs. No baseline. Van den
Brom and others 2012: 40% of malformed lambs tested
after pathology were SBV positive. It was assumed that
in the absence of a baseline, half of the observed effects
are due to SBV.
Probability of farmers applying insecticide
as SBV prevention
0 0 Expert opinion Given that the vector dynamics are still not fully
understood and therefore no evidence is available on the
effectiveness of insecticide treatment, farmers are highly
unlikely to use this as a measure to prevent SBV. Many
farmers will already use insecticides for fly strike, but it is
considered highly unlikely that a farmer would start using
it particularly for SBV.
Probability of an ewe with reproductive
problems to get culled
0.2 0.2 Expert opinion The majority of ewes with reproductive problems are
commonly kept in the flock and mated in the next
season. A minor proportion, in particular problem ewes,
will be culled and not kept for the next season.
Number of ewes out of 100 animals that
suffer from dystocia when they give birth to
a stillborn or malformed lamb due to SBV
80 80 (Saegerman and others 2013)
and expert opinion
Saegerman and others 2013: flock dystocia rate in
positive flocks was significantly higher compared with
negative flocks. The ratio of mean dystocia rate/
proportion stillborn and malformed lambs in positive
flocks was 0.8. This value was taken as the proportion of
malformed or stillborn calves that will cause dystocia in
ewes.
Continued
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TABLE 3: Continued
Parameter
Scenario 1—
high impact
Scenario 2—
low impact Reference Reasoning
Number of ewes requiring caesarean out
of 100 ewes with dystocia
2–10
most likely=5
2–10
most likely=5
(Thorne and Jackson, 2000) and
expert opinion
Thorne and Jackson 2000 estimated that 1% of all
dystocia problems in the UK required a caesarean. This
was based on a survey where fetal abnormalities
represented 3% of all dystocia cases. With an increased
proportion of malformations causing dystocia, it was
assumed that the need for caesareans would also
increase.
Number of ewes that die out of 100 ewes
with dystocia
50 50 (Scott, 2003) and expert opinion The number of ewes with dystocia in a survey of 89,000
ewes in the UK was 4313 with a mortality rate of 79.3%
for farmer assisted dystocia cases. Only 289 ewes (6.7%
of all dystocias) were presented to a veterinary surgeon.
It was assumed that the dystocia related mortality rate
would be lower, because of increased disease
awareness due to SBV. The value in the table
corresponds to the mortality rate of ewes that have
dystocia and not the absolute mortality rate in a herd due
to dystocia. When adjusted to the number of ewes with
dystocia, the absolute mortality rate of the herd
associated with this condition is 2.6–3.1%.
Number of dairy ewes with clinical
episodes out of 100 ewes
3–31
most
likely=7.5
0 (Martinelle and others, 2012) and
expert opinion
Martinelle and others 2012 report data for cattle, which
has been used as a proxy in this study for dairy sheep.
Median SBV morbidity rate in cattle was 7.5% which was
taken as the most likely value. The minimum reported by
Martinelle and others was taken as the lower range value
and the median value plus 1 SD as the upper range
value.
Duration of clinical episode in a ewe (days) 14–21
most likely=14
14–21
most
likely=14
(Martinelle and others, 2012) and
expert opinion
Martinelle and others 2012 was also used here as a
proxy for the dairy sheep system
Proportion daily milk drop in production in
a ewe with a SBV clinical episode
(proportion)
0.1 0.1 Expert opinion Due to lack of evidence on this effect, this figure was
derived from dairy cow values (Häsler and others, 2014,
unpublished data)
SBV, Schmallenberg virus
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For each scenario, input parameters were defined to
calculate the partial budget, as outlined in Table 3.
To complement the values derived from the scientific lit-
erature, the input values for the models were discussed
and agreed on in an expert workshop, as described in
‘Software, input values, sensitivity analysis and validation’
below. For the most variable and uncertain parameters,
minimum, most likely and maximum values were agreed
upon.
Software, input values, sensitivity analysis and validation
All models were built in Microsoft Excel. Apart from the
parameter values derived from the published literature,
two workshops were held, with 10 and 20 experts, respect-
ively, representing members of the Schmallenberg
surveillance team at the Animal Health Veterinary
Laboratories Agency, industry representatives, veterinary
clinicians and academic researchers. The first workshop
aimed to present and discuss the structure of the produc-
tion models, input variables and assumptions. Before the
meeting, experts were requested to complete table with
their opinion on the values of specific disease parameters
(Table 3), and their ranges, for the high and low impact
scenarios. The different expert estimates obtained and
their averages were presented to the experts during the
workshop for discussion. For the parameters with major
differences and uncertainties, all workshop participants
were encouraged to explain why they disagreed, and a
discussion was stimulated to get to an agreement on the
most appropriate value. Furthermore, the structure of
the production models, gross margin and partial budget
analysis were presented and discussed until agreement
was reached. The second workshop was held at the end
of the study, where the models developed and their
results were presented. Experts were asked for their
opinion on the validity of the results obtained. In add-
ition, gross margin results were compared with literature
estimates for validation purposes.
The sensitivity analysis was done by varying two vari-
ables: proportions of SBV abortions and proportion of
stillborn and malformed lambs. Selection of these
variables was done taking into account the uncertainty
attached to them and their hierarchical position in the
models. Uncertainty was determined considering the
range of estimates collated from the literature and
experts, and the input from discussions during the first
expert workshop. These were also selected because most
of the other disease effects in the models depend on
these two inputs. The variable percentage of stillborn
and malformed lambs due to SBV was varied in steps of
1 per cent between 0 per cent and 12 per cent, and the
variable percentage of ewes with late abortions due to
SBV was simultaneously varied between 0 per cent and 5
per cent. In addition, the models were run with all of
the lowest and highest values to estimate the range of
disease impact.
For the purposes of comparison and clarity, all eco-
nomic results are presented in pounds sterling (1£=1.2303
€, as consulted on 20 May 2014). Further information on
the production models is available on request.
RESULTS
Production models and gross margin analyses
The summarised results of the gross margin analyses
are shown in Fig 1. The detailed structure and results
of the production models and gross margin analyses of
non-SBV infected farms are shown in the online sup-
plement 2. For the UK, the model gross margin
obtained for lowland spring lambing (LSL), upland
spring lambing (USL) and lowland early lambing
(LEL) flocks were £38, £23 and £47 per ewe, respect-
ively. The main differences observed between the
model gross margins and the industry gross margins
(EBLEX 2012) are due to the estimation of replace-
ment and forage costs (see online supplementary
Fig 1). Replacement costs also explain some of the dif-
ferences with the gross margin calculated in the
Budgeting and costing book 2012.
In France, the model gross margins obtained for
GLCW, EL and dairy sheep flocks were £27, £32 and
£178 per ewe, respectively (see online supplement
FIG 1: Gross margin results for Schmallenberg virus free sheep farms in the UK and France, and comparison with other gross
margin analyses existent in the literature
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Fig 2). The higher revenues observed in dairy sheep
farms is due to the production of milk (71 per cent of
the revenues). The model gross margin estimations for
the GLCW and dairy sheep flocks are close to the gross
margin available in the literature (within the 7 and
9 per cent difference, respectively). However, the differ-
ence for the EL production type is 23 per cent. This is
due to the fact that these extensive livestock systems
include summer pasturing in farm distant highland
areas, and that these areas have particular juridical
status for the farms (own property, long term renting,
yearly renting), creating substantial variability.
Net SBV disease costs in sheep farms
The results of the net SBV disease costs for sheep farms
are shown in Tables 4 and 5.
In the high impact scenario in the UK, the net SBV
disease cost per ewe per year obtained in the PBA for an
average sheep farm was estimated at £19.65 for LSL
farms, £19.68 for USL farms and £20.85 for LEL farms
(Table 4). In all three production types, the costs mainly
accrued from young lambs not being sold (33–52
per ent of total new costs and revenues foregone) and
the replacement of ewes (23–26 per cent of total new
costs and revenues foregone). In the low impact scen-
ario in the UK, the net SBV disease cost per ewe and
year for an average sheep farm was estimated at £6.40
for LSL and USL farms and £6.58 for LEL farms
(Table 4). In all three production types, the costs mainly
accrued from young lambs not being sold (36–57 per
cent of total new costs and revenues foregone) and the
replacement of ewes (23–29 per cent of total new costs
and revenues foregone).
In France, the net SBV disease cost per ewe and
year for an average sheep farm in the high impact
scenario was estimated at £17.20 for GLCW farms,
£15.59 for EL farms and £29.81 for dairy sheep farms
(Table 5). In the meat sheep production types (GLCW
and EL), the costs mainly accrued from young lambs
not being sold (50–55 per cent of the sum of costs),
TABLE 4: Schmallenberg virus disease costs (£) for three types of meat sheep farms in the UK considering high impact and
low impact disease scenarios
Lowland
spring lambing
Upland spring
lambing
Early
lambing
HI LI HI LI HI LI
Additional expenditure
Treatment and veterinary assistance on ewes with late abortion 100 0 100 0 100 0
Caesareans due to SBV (veterinary visit and labour, drugs) 63 18 63 18 17 5
Disposal of aborted fetuses, stillborn or malformed lambs 38 14 50 17 10 3
Disposal of dead ewes due to SBV (consequence of dystocia) 6 2 6 2 2 0
Replacement of ewes culled or dead due to SBV 2386 761 1883 602 642 205
Chlamydia and toxoplasma vaccination of new ewes bought to
replace ewe culled or dead due to SBV
98 31 99 32 26 8
Revenues forgone
Finished lambs not sold 2710 964 3034 1142 1302 464
Store lambs not sold 1279 455 1530 531 27 10
Wool not sold 60 24 48 20 24 8
Dead ewes due to SBV (not culled and meat not sold) 1372 399 1069 311 369 107
Sum of costs 8112 2668 8141 2675 2516 812
Expenditure saved
Concentrate feed saved in finished lambs 49 17 93 32 209 74
Concentrate feed saved in store lambs 30 11 60 21 6 2
Lamb vaccines saved 40 14 36 13 10 4
Ewes vaccines saved for clostridium and pasteurella 3 2 3 2 1 0
Deworming saved in culled ewes 3 1 3 1 1 0
Deworming saved in lambs not reared 6 2 5 2 1 0
Bedding saved in ewes culled 7 3 7 3 2 1
Shearing saved in ewes culled 28 9 28 9 8 2
Costs saved in marketing, levy and transport on lambs not reared 208 74 231 80 56 20
Minerals and licks saved 16 8 16 8 4 2
Extra revenues
Revenues from ewes culled due to SBV 493 176 418 150 133 48
Sum of benefits 881 317 900 320 430 154
Net total disease cost 7231 2352 7242 2355 2085 658
Average flock size (heads) 368 368 368 368 100 100
Net total disease cost/ewe 19.65 6.40 19.68 6.40 20.85 6.58
HI, high impact; LI, low impact; SBV, Schmallenberg virus
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replacement of ewes (22 per cent of the sum of costs)
and revenues forgone from dead ewes due to SBV
(12–13 per cent of the sum of costs). For dairy sheep,
the main costs were related to the revenues forgone
on milk by ewes culled or dead due to SBV (45 per
cent of the sum of costs) and revenues forgone by not
selling replacement lambs (38 per cent of the sum of
costs).
The net SBV disease cost per ewe and year for an
average sheep farm in the low impact scenario was esti-
mated at £5.26 for GLCW farms, £4.75 for EL farms and
£29.81 for dairy sheep farms (Table 5). In the meat
sheep production type (GLCW and EL), the costs
mainly accrued from young lambs not being sold (57–61
per cent of the sum of costs), replacement of ewes
(22–23 per cent of the sum of costs) and revenues
forgone from dead ewes due to SBV (12–13 per cent of
sum of costs). For dairy sheep, the main costs were
related to the revenues forgone on milk by ewes culled
or dead due to SBV (50 per cent of the sum of costs)
and revenues forgone by not selling replacement lambs
(37 per cent of the sum of costs).
Comparison of gross margins with and without SBV
The impact of SBV on the farm gross margins is shown
in Fig 2. They illustrate the gross margin (expressed as
£/ewe/year) for a farm not infected with SBV, a highly
affected farm and a slightly affected farm. The reduc-
tions in gross margins for the UK for the high impact
scenario are 43 per cent for LSL farms, 76 per cent for
USL farms and 37 per cent for LEL farms. For the low
impact scenario, the reductions are 14 per cent, 25 per
cent and 12 per cent, respectively. The reductions in
gross margins for France for the high impact scenario
TABLE 5: Schmallenberg virus disease costs (£) for three types of sheep farms in France considering high impact and low
impact disease scenarios
Grass lamb
flocks of the
Centre and
West France
Extensive
lambing
flocks Dairy sheep
HI LI HI LI HI LI
Additional expenditure
Treatment and veterinary assistance on ewes with late abortion 114 0 114 0 114 0
Caesareans due to SBV (veterinary visit and labour, drugs) 11 3 11 3 11 3
Replacement of ewes culled or dead due to SBV 436 139 395 126 73 24
Chlamydia and toxoplasma vaccination of new ewes bought to replace ewe
culled or dead due to SBV
35 11 35 11 34 11
Revenues forgone
Finished lambs not sold 1109 392 899 319 264 93
Store lambs not sold 60 21 100 37 0 0
Replacement lambs not sold 0 0 0 0 1209 411
Milk not produced and sold from dead and culled ewes due to SBV 0 0 0 0 1443 564
Milk not produced by ewes with clinical signs and first lambing and by extra
ewes in first lambing
0 0 0 0 102 15
Dead ewes due to SBV (not culled and meat not sold) 251 73 228 66 42 12
Sum of costs 2015 639 1782 560 3189 1119
Expenditure saved
Concentrate feed saved in finished lambs 137 49 89 31 26 10
Concentrate feed saved in store lambs 10 3 11 4 0 0
Concentrate saved on aborted ewes 40 20 30 15 88 40
Lamb vaccines saved 7 2 7 2 0 0
Ewes vaccines saved for clostridium and pasteurella 3 2 3 2 3 2
Deworming saved in culled ewes 2 1 2 1 2 1
Deworming saved in lambs not reared 2 1 2 1 1 0
Bedding saved in ewes culled 7 3 5 2 7 3
Costs saved in marketing, levy and transport on lambs not reared 15 6 15 6 15 6
Minerals and licks saved 4 2 2 2 6 2
Extra revenues
Revenues from ewes culled due to SBV 295 112 224 85 215 85
Sum of benefits 295 112 224 85 215 85
Net total disease cost 1720 526 1559 475 2981 1034
Average flock size (heads) 100 100 100 100 100 100
Net total disease cost/ewe 17.20 5.26 15.67 4.75 29.81 10.34
HI, high impact; LI, low impact; SBV, Schmallenberg virus
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are 55 per cent for GLCW farms, 42 per cent for EL
farms and 17 per cent for dairy sheep farms. For the low
impact scenario, the reductions are 16 per cent, 13 per
cent and 6 per cent, respectively.
Results from sensitivity analyses
Sensitivity analyses were performed for two of the most
sensitive and uncertain disease parameters. The vari-
ation in the net SBV disease cost (£) per ewe per year
are illustrated in Fig 3. The results show a linear increase
in the costs of the disease. However, it can be observed
that a substantial increase in the costs occurs when the
proportion of ewes with malformations reaches 3 per
cent. This is due to the assumption that at this level of
abortion, the farmer will call in the veterinarian for
investigation (Box 1).
The range from the best case (using the minimum
values for all disease inputs from Table 3) to the worst
case (using the maximum values for all disease inputs
from Table 3) for the high impact scenario was
£5.78–£31.64 per ewe and year for LSL farms,
£5.79–£31.69 per ewe and year for USL farms and
£5.93–£33.05 per ewe and year for LEL farms. For the
low impact scenario, the ranges per ewe and year were
estimated at £3.49–£9.32 for LSL farms, £3.50–£9.33 for
USL farms and £3.61–£9.58 for LEL farms.
The net SBV disease cost ranges from the best case
(using the minimum values for all disease inputs) to the
worst case (using the maximum values for all disease
inputs as defined in Table 3) for the high impact scen-
ario (in £/ewe/year) were 4.8–27.1 for GLCW farms,
4.3–24.5 for EL farms and 8.8–45.1 for dairy sheep
farms. For the low impact scenario, the ranges of net
SBV disease cost (in £/ewe/year) were 2.8–7.6 for
GLCW farms, 2.6–6.9 for EL farms and 6.0–14.7 for
dairy sheep farms.
DISCUSSION
The present study aimed to estimate and compare the
financial impact of SBV in different sheep production
holdings in the UK and France using partial budget and
gross margin analysis in combination with production
models. The integration of production models with
gross margin and partial budget analysis models can be
a reliable method to assess disease impact. In the first
instance, some disease parameters have a cascade effect
on the economics of the farm. For example, an increase
in abortions means that fewer lambs are born, which
mean less revenues, but also more ewes dead or culled
because of the abortion. This, if it is a closed farm,
means that more lambs are kept for replacement and
FIG 3: Variation of the net value (Schmallenberg virus disease impact) for (A) different values of percentages of stillborn and
malformations (legend indicates different values of abortions) and (B) for different values of late abortions (legend indicates
different values of proportion of stillborn and malformed lambs)
FIG 2: Gross margins for not Schmallenberg virus (SBV) affected, and highly and slightly SBV affected sheep farms in the UK
and France
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fewer lambs are finished, resulting in a loss in revenues.
Production models can be used to calculate these effects
in an easy and reliable way and allow capturing invisible
direct costs related to changing population dynamics.
They allow the assessment of how the population dynam-
ics change due to disease. These changes can then be
used to estimate the financial impact of a varying disease
parameter. Although a straightforward partial budget
analysis could have been done, some disease effects
would have been difficult to estimate and the probability
of model error would have been higher. Production
models also help to estimate the gross margin of a farm,
by understanding and quantifying the different inputs
and outputs arising. This allows for comparison of
outcome of the gross margin with the literature/bench-
marking data. This comparison is important to validate
the models (assess that the results are similar to the lit-
erature estimates) and to understand where the bias of
the model lies. Furthermore, production models provide
the basis to account for differences in production types.
It is, however, important to note that the net value
obtained in the partial budget analysis is equivalent to
the difference in the gross margins with and without
disease.
The UK and France sheep production types were
chosen for this study for several reasons. These
countries are among the most important sheep produ-
cers in the European Union (first and fourth largest
producers) (Eurostat 2013). In terms of comparison of
different sheep production types, important differences
were expected between lowland and highland systems,
due to the impact that the disease has on the reproduc-
tion of animals. The UK and France provide a good
opportunity to investigate this, as they have both types of
systems but in different settings (lowland/grassland v
upland/EL). In addition, France has a large sheep dairy
production which represents an important different
farm type to investigate.
The results obtained indicate that the costs of SBV are
similar for the different meat sheep production types of
both countries. However, the impact on profitability was
found to be most severe in the UK upland lambing
flocks (with a 76 per cent reduction in gross profits) and
in the French GLCW flocks (with a 55 per cent reduc-
tion in gross profits). The major costs of the disease
were associated with the replacement of ewes culled or
dead due to SBV and to the revenues foregone from fin-
ished lambs. For the UK, the losses due to the first par-
ameter were higher in LSL flocks and in early lambing
flocks, as these farms need to buy in replacement ewes.
For France, the replacement costs of ewes culled or
dead due to SBV were considerably higher in GLCW
and EL compared with dairy sheep, for the same reason
as in the UK. These results indicate that the common
restocking procedures are a major disease costs element.
The losses due to finished lambs not sold were found to
be higher for early lambing flocks (£13/ewe) compared
with lowland lambing flocks (£7.4/ewe if highly
affected) and upland lambing flock (£8.2/ewe if highly
affected). This is due to the higher value of the finished
lambs in LEL flocks. However, it is important to note
that the models do not account for farms selling breed-
ing ewes. It is hypothesised that the costs of SBV for
such farms will be considerably higher due to the loss
generated by not being able to sell high value breeding
ewes. For the French dairy sheep production type the
net SBV disease cost was higher than for the other pro-
duction types. In contrast, the disease impact on the
gross margin was lower. This is mainly due to the fact
that this farm type has much higher gross margin values
due to revenues from milk production.
Importantly, the likelihood of being highly or slightly
affected by the disease may differ substantially between
the different production types due to management prac-
tices and related epidemiological factors. For instance,
early lambing flocks may be more likely to be slightly
affected by the disease due to the fact that their ewes are
at risk of infection during the early gestation period,
while lowland and upland flocks would most likely be
infected during late gestation (Lievaart-Peterson and
others 2012). Other factors that reduce the vector popu-
lation (such as altitude, housing, etc) in the vicinity of
the flock might contribute to this probability. Moreover,
susceptibility of the animals (first infection or reinfec-
tion) may also influence the likelihood of being highly
affected, although there is still much uncertainty about
the duration and effectiveness of natural immunity. For
France, no major differences in the contribution of the
total costs of disease were seen between the GLCW and
EL production types.
The SBV impact in milk sheep was almost twice that
compared with meat sheep production. Yet the gross
margin was approximately five times higher for dairy
sheep, leading to a lower relative impact on profits for
dairy compared with meat sheep. In dairy sheep farms,
the highest losses accrued from the milk sales foregone
followed by the revenues from replacement lambs not
sold and to a much lesser extent from finished lambs
not sold, veterinary expenditures and concentrate saved
on aborted ewes. Assumptions made on sheep dairy pro-
duction were principally derived from expert opinion on
dairy cattle, and the results need to be interpreted with
great care. However, the authors believe that the dairy
cow data are a plausible approximation for dairy ewes in
the absence of robust data.
In this study, the financial impact was presented for a
low impact scenario and a high impact scenario without
providing any information on the likelihood of a farm
being in the high impact or low impact category.
Although several extreme SBV clinical incidences have
been reported by farmers, these were not considered in
the analysis due to a lack of scientifically based evidence
of a causal relationship between SBV and such cases.
Furthermore, the impact of SBV on ewe fertility (i.e.
empty ewes) was not considered in this study because
there are currently no epidemiological data available to
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corroborate this hypothesis and there is a need for more
in depth studies and data collection. As a consequence,
an underestimation of disease impact may have occurred.
Once scientific evidence becomes available, the models
can be updated with the newly published data.
One of the main limitations of this study was the lack
of data available in the literature on SBV disease effects,
which may be partly due to a lack of reporting and
absence of incentives for reporting. Most of the pub-
lished scientific literature described the situation on
Schmallenberg affected farms, but only in some excep-
tional cases compared them with non-affected farms or
previous years before SBV emergence. As a conse-
quence, attribution of disease estimates was not possible
from these studies. Experimental studies or epidemio-
logical studies comparing affected and non-affected
farms are needed in order to obtain more accurate
disease estimates. Expert opinion consultation was then
needed to assess some of the parameters and assump-
tions. For instance, it was assumed that adult sheep do
not show clinical signs apart from reproductive problems
and milk loss. Also, although there is anecdotal evidence
that SBV may cause infertility in ewes (empty ewes), this
has not been corroborated by systematic scientific
studies. The diversity of factors involved makes it very dif-
ficult for farmers and experts to establish a causal effect
of SBV infection. In depth epidemiological and labora-
tory investigations would be needed to assess the reason
for the infertility problem. Therefore, this clinical mani-
festation was not considered in this study. For dairy
sheep it was assumed that adult sheep show clinical epi-
sodes with milk drop during the clinical episode, but
milk production will return to normal when the ewe
recovers (Doceul and others 2013). The disease esti-
mates and assumptions used in this study were derived
from scientific publications when possible and comple-
mented by expert opinion consultation. Sensitivity ana-
lyses on disease estimates were used to account for this
uncertainty and demonstrate the influence of the most
uncertain input values used.
Importantly, only variable costs were included in this
study. Labour costs were considered as fixed costs
with the assumption that farmers would not pay extra
time or increase staff numbers because of the disease.
Furthermore, the models calculate the costs of disease
without accounting for the costs of planned control and
preventive measures, such as vaccination. While the costs
of veterinary visits to treat affected animals are calculated,
the costs of vaccination or preventive measures are not
taken into account. These could be investigated in future
studies aimed at assessing the efficiency of control
measures.
In conclusion, although disease costs were found to be
similar in all of the production types investigated, the
UK USL flocks and the French GCLW flocks were shown
to be most affected. The impact of SBV in high impact
scenarios has been shown to be important for the farm
in terms of costs (with up to £21 per ewe or 76 per cent
reduction in profits). The models highlights that the
main financial impact was due to ‘finished lambs not
being sold’ and ‘replacement of ewes culled or dead
due to SBV’. This demonstrates that production systems
can be affected very differently due to their different
characteristics (prices, geography, management, etc)
and highlights the validity of the approach chosen.
Control measures aimed at reducing the impact of SBV
in these sheep farm types should be considered.
However, it is important to note that for farmers to
make informed decisions on disease control, it is not suf-
ficient to know the aggregate economic costs of the
disease, but to understand what would be the avoidable
disease costs (McInerney and others 1992). These avoid-
able costs will depend on the cost effectiveness of the
different control measures available. Presently, the
novelty of the disease and the lack of information on
the effectiveness of control measures makes it difficult to
incorporate this. However, the models presented here
provide an important baseline that could be used as a
basis to analyse the efficiency of possible SBV control
strategies for different farm management systems by
using, for example, cost–benefit analysis. Finally, this
study shows the lack of data available in the literature
regarding SBV disease parameters and indicates the
necessity for further studies to accurately assess key
disease parameters, such as the proportion of stillborn
and malformed lambs and the proportion of ewes abort-
ing due to SBV.
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